nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—prostate cancer—Dexamethasone—ankylosing spondylitis	0.325	0.5	CpDpCtD
Fentanyl—prostate cancer—Betamethasone—ankylosing spondylitis	0.325	0.5	CpDpCtD
Fentanyl—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0304	0.125	CbGbCtD
Fentanyl—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0261	0.108	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0202	0.0834	CbGbCtD
Fentanyl—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0202	0.0834	CbGbCtD
Fentanyl—ABCB1—Betamethasone—ankylosing spondylitis	0.017	0.07	CbGbCtD
Fentanyl—ABCB1—Prednisolone—ankylosing spondylitis	0.0167	0.069	CbGbCtD
Fentanyl—ABCB1—Prednisone—ankylosing spondylitis	0.0158	0.0652	CbGbCtD
Fentanyl—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0156	0.0645	CbGbCtD
Fentanyl—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0152	0.0625	CbGbCtD
Fentanyl—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0118	0.0489	CbGbCtD
Fentanyl—CYP3A4—Betamethasone—ankylosing spondylitis	0.0102	0.0419	CbGbCtD
Fentanyl—CYP3A4—Prednisolone—ankylosing spondylitis	0.01	0.0414	CbGbCtD
Fentanyl—ABCB1—Dexamethasone—ankylosing spondylitis	0.00987	0.0407	CbGbCtD
Fentanyl—CYP3A4—Prednisone—ankylosing spondylitis	0.00947	0.0391	CbGbCtD
Fentanyl—ABCB1—Methotrexate—ankylosing spondylitis	0.00793	0.0327	CbGbCtD
Fentanyl—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00591	0.0244	CbGbCtD
Fentanyl—Shock—Methylprednisolone—ankylosing spondylitis	7.25e-05	0.000679	CcSEcCtD
Fentanyl—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	7.23e-05	0.000677	CcSEcCtD
Fentanyl—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	7.23e-05	0.000677	CcSEcCtD
Fentanyl—Loss of consciousness—Dexamethasone—ankylosing spondylitis	7.22e-05	0.000676	CcSEcCtD
Fentanyl—Loss of consciousness—Betamethasone—ankylosing spondylitis	7.22e-05	0.000676	CcSEcCtD
Fentanyl—Epistaxis—Methotrexate—ankylosing spondylitis	7.21e-05	0.000676	CcSEcCtD
Fentanyl—Paraesthesia—Prednisolone—ankylosing spondylitis	7.21e-05	0.000675	CcSEcCtD
Fentanyl—Tachycardia—Triamcinolone—ankylosing spondylitis	7.21e-05	0.000675	CcSEcCtD
Fentanyl—Mental disorder—Prednisone—ankylosing spondylitis	7.2e-05	0.000674	CcSEcCtD
Fentanyl—Tachycardia—Methylprednisolone—ankylosing spondylitis	7.19e-05	0.000674	CcSEcCtD
Fentanyl—Skin disorder—Methylprednisolone—ankylosing spondylitis	7.16e-05	0.00067	CcSEcCtD
Fentanyl—Malnutrition—Prednisone—ankylosing spondylitis	7.15e-05	0.00067	CcSEcCtD
Fentanyl—Erythema—Prednisone—ankylosing spondylitis	7.15e-05	0.00067	CcSEcCtD
Fentanyl—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.14e-05	0.000669	CcSEcCtD
Fentanyl—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.12e-05	0.000667	CcSEcCtD
Fentanyl—Convulsion—Dexamethasone—ankylosing spondylitis	7.11e-05	0.000666	CcSEcCtD
Fentanyl—Convulsion—Betamethasone—ankylosing spondylitis	7.11e-05	0.000666	CcSEcCtD
Fentanyl—Hypertension—Dexamethasone—ankylosing spondylitis	7.09e-05	0.000664	CcSEcCtD
Fentanyl—Hypertension—Betamethasone—ankylosing spondylitis	7.09e-05	0.000664	CcSEcCtD
Fentanyl—Myalgia—Dexamethasone—ankylosing spondylitis	6.99e-05	0.000655	CcSEcCtD
Fentanyl—Myalgia—Betamethasone—ankylosing spondylitis	6.99e-05	0.000655	CcSEcCtD
Fentanyl—Anxiety—Dexamethasone—ankylosing spondylitis	6.97e-05	0.000653	CcSEcCtD
Fentanyl—Anxiety—Betamethasone—ankylosing spondylitis	6.97e-05	0.000653	CcSEcCtD
Fentanyl—Discomfort—Betamethasone—ankylosing spondylitis	6.91e-05	0.000647	CcSEcCtD
Fentanyl—Discomfort—Dexamethasone—ankylosing spondylitis	6.91e-05	0.000647	CcSEcCtD
Fentanyl—Haemoglobin—Methotrexate—ankylosing spondylitis	6.9e-05	0.000646	CcSEcCtD
Fentanyl—Hypotension—Methylprednisolone—ankylosing spondylitis	6.89e-05	0.000645	CcSEcCtD
Fentanyl—Pain—Prednisolone—ankylosing spondylitis	6.87e-05	0.000643	CcSEcCtD
Fentanyl—Haemorrhage—Methotrexate—ankylosing spondylitis	6.87e-05	0.000643	CcSEcCtD
Fentanyl—Pharyngitis—Methotrexate—ankylosing spondylitis	6.81e-05	0.000638	CcSEcCtD
Fentanyl—Urinary tract disorder—Methotrexate—ankylosing spondylitis	6.78e-05	0.000635	CcSEcCtD
Fentanyl—Vision blurred—Prednisone—ankylosing spondylitis	6.74e-05	0.000631	CcSEcCtD
Fentanyl—Urethral disorder—Methotrexate—ankylosing spondylitis	6.73e-05	0.00063	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	6.73e-05	0.00063	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	6.71e-05	0.000629	CcSEcCtD
Fentanyl—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	6.7e-05	0.000628	CcSEcCtD
Fentanyl—Oedema—Dexamethasone—ankylosing spondylitis	6.7e-05	0.000628	CcSEcCtD
Fentanyl—Anaphylactic shock—Betamethasone—ankylosing spondylitis	6.7e-05	0.000628	CcSEcCtD
Fentanyl—Oedema—Betamethasone—ankylosing spondylitis	6.7e-05	0.000628	CcSEcCtD
Fentanyl—Insomnia—Triamcinolone—ankylosing spondylitis	6.68e-05	0.000626	CcSEcCtD
Fentanyl—Insomnia—Methylprednisolone—ankylosing spondylitis	6.67e-05	0.000624	CcSEcCtD
Fentanyl—Infection—Dexamethasone—ankylosing spondylitis	6.66e-05	0.000624	CcSEcCtD
Fentanyl—Infection—Betamethasone—ankylosing spondylitis	6.66e-05	0.000624	CcSEcCtD
Fentanyl—Ill-defined disorder—Prednisone—ankylosing spondylitis	6.64e-05	0.000621	CcSEcCtD
Fentanyl—Paraesthesia—Triamcinolone—ankylosing spondylitis	6.63e-05	0.000621	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisolone—ankylosing spondylitis	6.62e-05	0.00062	CcSEcCtD
Fentanyl—Paraesthesia—Methylprednisolone—ankylosing spondylitis	6.62e-05	0.00062	CcSEcCtD
Fentanyl—Visual impairment—Methotrexate—ankylosing spondylitis	6.62e-05	0.00062	CcSEcCtD
Fentanyl—Anaemia—Prednisone—ankylosing spondylitis	6.61e-05	0.000619	CcSEcCtD
Fentanyl—Shock—Betamethasone—ankylosing spondylitis	6.59e-05	0.000618	CcSEcCtD
Fentanyl—Shock—Dexamethasone—ankylosing spondylitis	6.59e-05	0.000618	CcSEcCtD
Fentanyl—Dyspnoea—Triamcinolone—ankylosing spondylitis	6.59e-05	0.000617	CcSEcCtD
Fentanyl—Nervous system disorder—Betamethasone—ankylosing spondylitis	6.57e-05	0.000616	CcSEcCtD
Fentanyl—Nervous system disorder—Dexamethasone—ankylosing spondylitis	6.57e-05	0.000616	CcSEcCtD
Fentanyl—Agitation—Prednisone—ankylosing spondylitis	6.57e-05	0.000616	CcSEcCtD
Fentanyl—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	6.56e-05	0.000615	CcSEcCtD
Fentanyl—Thrombocytopenia—Betamethasone—ankylosing spondylitis	6.56e-05	0.000615	CcSEcCtD
Fentanyl—Tachycardia—Betamethasone—ankylosing spondylitis	6.54e-05	0.000613	CcSEcCtD
Fentanyl—Tachycardia—Dexamethasone—ankylosing spondylitis	6.54e-05	0.000613	CcSEcCtD
Fentanyl—Dyspepsia—Triamcinolone—ankylosing spondylitis	6.5e-05	0.000609	CcSEcCtD
Fentanyl—Erythema multiforme—Methotrexate—ankylosing spondylitis	6.49e-05	0.000608	CcSEcCtD
Fentanyl—Dyspepsia—Methylprednisolone—ankylosing spondylitis	6.49e-05	0.000608	CcSEcCtD
Fentanyl—Hyperhidrosis—Betamethasone—ankylosing spondylitis	6.48e-05	0.000607	CcSEcCtD
Fentanyl—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	6.48e-05	0.000607	CcSEcCtD
Fentanyl—Malaise—Prednisone—ankylosing spondylitis	6.45e-05	0.000604	CcSEcCtD
Fentanyl—Vertigo—Prednisone—ankylosing spondylitis	6.43e-05	0.000602	CcSEcCtD
Fentanyl—Eye disorder—Methotrexate—ankylosing spondylitis	6.42e-05	0.000601	CcSEcCtD
Fentanyl—Syncope—Prednisone—ankylosing spondylitis	6.41e-05	0.000601	CcSEcCtD
Fentanyl—Tinnitus—Methotrexate—ankylosing spondylitis	6.4e-05	0.0006	CcSEcCtD
Fentanyl—Anorexia—Dexamethasone—ankylosing spondylitis	6.39e-05	0.000598	CcSEcCtD
Fentanyl—Anorexia—Betamethasone—ankylosing spondylitis	6.39e-05	0.000598	CcSEcCtD
Fentanyl—Urticaria—Prednisolone—ankylosing spondylitis	6.38e-05	0.000598	CcSEcCtD
Fentanyl—Cardiac disorder—Methotrexate—ankylosing spondylitis	6.37e-05	0.000597	CcSEcCtD
Fentanyl—Fatigue—Triamcinolone—ankylosing spondylitis	6.37e-05	0.000596	CcSEcCtD
Fentanyl—Fatigue—Methylprednisolone—ankylosing spondylitis	6.35e-05	0.000595	CcSEcCtD
Fentanyl—Pain—Triamcinolone—ankylosing spondylitis	6.32e-05	0.000592	CcSEcCtD
Fentanyl—Loss of consciousness—Prednisone—ankylosing spondylitis	6.29e-05	0.000589	CcSEcCtD
Fentanyl—Hypotension—Dexamethasone—ankylosing spondylitis	6.26e-05	0.000587	CcSEcCtD
Fentanyl—Hypotension—Betamethasone—ankylosing spondylitis	6.26e-05	0.000587	CcSEcCtD
Fentanyl—Angiopathy—Methotrexate—ankylosing spondylitis	6.23e-05	0.000583	CcSEcCtD
Fentanyl—Immune system disorder—Methotrexate—ankylosing spondylitis	6.2e-05	0.000581	CcSEcCtD
Fentanyl—Convulsion—Prednisone—ankylosing spondylitis	6.2e-05	0.00058	CcSEcCtD
Fentanyl—Mediastinal disorder—Methotrexate—ankylosing spondylitis	6.19e-05	0.00058	CcSEcCtD
Fentanyl—Hypertension—Prednisone—ankylosing spondylitis	6.17e-05	0.000578	CcSEcCtD
Fentanyl—Chills—Methotrexate—ankylosing spondylitis	6.16e-05	0.000577	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.11e-05	0.000572	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.11e-05	0.000572	CcSEcCtD
Fentanyl—Arthralgia—Prednisone—ankylosing spondylitis	6.09e-05	0.00057	CcSEcCtD
Fentanyl—Myalgia—Prednisone—ankylosing spondylitis	6.09e-05	0.00057	CcSEcCtD
Fentanyl—Feeling abnormal—Triamcinolone—ankylosing spondylitis	6.09e-05	0.00057	CcSEcCtD
Fentanyl—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	6.07e-05	0.000569	CcSEcCtD
Fentanyl—Anxiety—Prednisone—ankylosing spondylitis	6.07e-05	0.000568	CcSEcCtD
Fentanyl—Alopecia—Methotrexate—ankylosing spondylitis	6.07e-05	0.000568	CcSEcCtD
Fentanyl—Insomnia—Betamethasone—ankylosing spondylitis	6.06e-05	0.000568	CcSEcCtD
Fentanyl—Insomnia—Dexamethasone—ankylosing spondylitis	6.06e-05	0.000568	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	6.05e-05	0.000566	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.03e-05	0.000564	CcSEcCtD
Fentanyl—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.02e-05	0.000564	CcSEcCtD
Fentanyl—Paraesthesia—Betamethasone—ankylosing spondylitis	6.02e-05	0.000564	CcSEcCtD
Fentanyl—Discomfort—Prednisone—ankylosing spondylitis	6.02e-05	0.000563	CcSEcCtD
Fentanyl—Mental disorder—Methotrexate—ankylosing spondylitis	6.02e-05	0.000563	CcSEcCtD
Fentanyl—Malnutrition—Methotrexate—ankylosing spondylitis	5.98e-05	0.00056	CcSEcCtD
Fentanyl—Erythema—Methotrexate—ankylosing spondylitis	5.98e-05	0.00056	CcSEcCtD
Fentanyl—Hypersensitivity—Prednisolone—ankylosing spondylitis	5.92e-05	0.000554	CcSEcCtD
Fentanyl—Dyspepsia—Betamethasone—ankylosing spondylitis	5.9e-05	0.000553	CcSEcCtD
Fentanyl—Dyspepsia—Dexamethasone—ankylosing spondylitis	5.9e-05	0.000553	CcSEcCtD
Fentanyl—Urticaria—Triamcinolone—ankylosing spondylitis	5.87e-05	0.00055	CcSEcCtD
Fentanyl—Urticaria—Methylprednisolone—ankylosing spondylitis	5.85e-05	0.000548	CcSEcCtD
Fentanyl—Dysgeusia—Methotrexate—ankylosing spondylitis	5.85e-05	0.000548	CcSEcCtD
Fentanyl—Body temperature increased—Triamcinolone—ankylosing spondylitis	5.84e-05	0.000547	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisone—ankylosing spondylitis	5.84e-05	0.000547	CcSEcCtD
Fentanyl—Oedema—Prednisone—ankylosing spondylitis	5.84e-05	0.000547	CcSEcCtD
Fentanyl—Abdominal pain—Methylprednisolone—ankylosing spondylitis	5.83e-05	0.000546	CcSEcCtD
Fentanyl—Decreased appetite—Betamethasone—ankylosing spondylitis	5.83e-05	0.000546	CcSEcCtD
Fentanyl—Decreased appetite—Dexamethasone—ankylosing spondylitis	5.83e-05	0.000546	CcSEcCtD
Fentanyl—Infection—Prednisone—ankylosing spondylitis	5.8e-05	0.000543	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	5.79e-05	0.000542	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	5.79e-05	0.000542	CcSEcCtD
Fentanyl—Back pain—Methotrexate—ankylosing spondylitis	5.78e-05	0.000541	CcSEcCtD
Fentanyl—Fatigue—Betamethasone—ankylosing spondylitis	5.78e-05	0.000541	CcSEcCtD
Fentanyl—Fatigue—Dexamethasone—ankylosing spondylitis	5.78e-05	0.000541	CcSEcCtD
Fentanyl—Shock—Prednisone—ankylosing spondylitis	5.74e-05	0.000538	CcSEcCtD
Fentanyl—Pain—Betamethasone—ankylosing spondylitis	5.73e-05	0.000537	CcSEcCtD
Fentanyl—Pain—Dexamethasone—ankylosing spondylitis	5.73e-05	0.000537	CcSEcCtD
Fentanyl—Nervous system disorder—Prednisone—ankylosing spondylitis	5.72e-05	0.000536	CcSEcCtD
Fentanyl—Tachycardia—Prednisone—ankylosing spondylitis	5.7e-05	0.000534	CcSEcCtD
Fentanyl—Skin disorder—Prednisone—ankylosing spondylitis	5.67e-05	0.000531	CcSEcCtD
Fentanyl—Hyperhidrosis—Prednisone—ankylosing spondylitis	5.64e-05	0.000528	CcSEcCtD
Fentanyl—Vision blurred—Methotrexate—ankylosing spondylitis	5.63e-05	0.000528	CcSEcCtD
Fentanyl—Anorexia—Prednisone—ankylosing spondylitis	5.56e-05	0.000521	CcSEcCtD
Fentanyl—Ill-defined disorder—Methotrexate—ankylosing spondylitis	5.55e-05	0.000519	CcSEcCtD
Fentanyl—Anaemia—Methotrexate—ankylosing spondylitis	5.52e-05	0.000517	CcSEcCtD
Fentanyl—Feeling abnormal—Betamethasone—ankylosing spondylitis	5.52e-05	0.000517	CcSEcCtD
Fentanyl—Feeling abnormal—Dexamethasone—ankylosing spondylitis	5.52e-05	0.000517	CcSEcCtD
Fentanyl—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.48e-05	0.000513	CcSEcCtD
Fentanyl—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.48e-05	0.000513	CcSEcCtD
Fentanyl—Hypersensitivity—Triamcinolone—ankylosing spondylitis	5.44e-05	0.00051	CcSEcCtD
Fentanyl—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	5.43e-05	0.000509	CcSEcCtD
Fentanyl—Malaise—Methotrexate—ankylosing spondylitis	5.39e-05	0.000505	CcSEcCtD
Fentanyl—Vertigo—Methotrexate—ankylosing spondylitis	5.37e-05	0.000503	CcSEcCtD
Fentanyl—Leukopenia—Methotrexate—ankylosing spondylitis	5.35e-05	0.000501	CcSEcCtD
Fentanyl—Urticaria—Betamethasone—ankylosing spondylitis	5.32e-05	0.000499	CcSEcCtD
Fentanyl—Urticaria—Dexamethasone—ankylosing spondylitis	5.32e-05	0.000499	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.32e-05	0.000498	CcSEcCtD
Fentanyl—Dizziness—Prednisolone—ankylosing spondylitis	5.31e-05	0.000497	CcSEcCtD
Fentanyl—Asthenia—Triamcinolone—ankylosing spondylitis	5.3e-05	0.000496	CcSEcCtD
Fentanyl—Body temperature increased—Betamethasone—ankylosing spondylitis	5.3e-05	0.000496	CcSEcCtD
Fentanyl—Abdominal pain—Betamethasone—ankylosing spondylitis	5.3e-05	0.000496	CcSEcCtD
Fentanyl—Body temperature increased—Dexamethasone—ankylosing spondylitis	5.3e-05	0.000496	CcSEcCtD
Fentanyl—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.3e-05	0.000496	CcSEcCtD
Fentanyl—Asthenia—Methylprednisolone—ankylosing spondylitis	5.29e-05	0.000495	CcSEcCtD
Fentanyl—Insomnia—Prednisone—ankylosing spondylitis	5.28e-05	0.000494	CcSEcCtD
Fentanyl—Paraesthesia—Prednisone—ankylosing spondylitis	5.24e-05	0.000491	CcSEcCtD
Fentanyl—Pruritus—Triamcinolone—ankylosing spondylitis	5.23e-05	0.000489	CcSEcCtD
Fentanyl—Cough—Methotrexate—ankylosing spondylitis	5.22e-05	0.000488	CcSEcCtD
Fentanyl—Pruritus—Methylprednisolone—ankylosing spondylitis	5.21e-05	0.000488	CcSEcCtD
Fentanyl—Convulsion—Methotrexate—ankylosing spondylitis	5.18e-05	0.000485	CcSEcCtD
Fentanyl—Dyspepsia—Prednisone—ankylosing spondylitis	5.14e-05	0.000481	CcSEcCtD
Fentanyl—Myalgia—Methotrexate—ankylosing spondylitis	5.09e-05	0.000477	CcSEcCtD
Fentanyl—Chest pain—Methotrexate—ankylosing spondylitis	5.09e-05	0.000477	CcSEcCtD
Fentanyl—Arthralgia—Methotrexate—ankylosing spondylitis	5.09e-05	0.000477	CcSEcCtD
Fentanyl—Decreased appetite—Prednisone—ankylosing spondylitis	5.07e-05	0.000475	CcSEcCtD
Fentanyl—Rash—Prednisolone—ankylosing spondylitis	5.06e-05	0.000474	CcSEcCtD
Fentanyl—Dermatitis—Prednisolone—ankylosing spondylitis	5.06e-05	0.000474	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	5.05e-05	0.000473	CcSEcCtD
Fentanyl—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.04e-05	0.000472	CcSEcCtD
Fentanyl—Fatigue—Prednisone—ankylosing spondylitis	5.03e-05	0.000471	CcSEcCtD
Fentanyl—Headache—Prednisolone—ankylosing spondylitis	5.03e-05	0.000471	CcSEcCtD
Fentanyl—Discomfort—Methotrexate—ankylosing spondylitis	5.03e-05	0.000471	CcSEcCtD
Fentanyl—Constipation—Prednisone—ankylosing spondylitis	4.99e-05	0.000467	CcSEcCtD
Fentanyl—Confusional state—Methotrexate—ankylosing spondylitis	4.92e-05	0.000461	CcSEcCtD
Fentanyl—Dizziness—Triamcinolone—ankylosing spondylitis	4.88e-05	0.000457	CcSEcCtD
Fentanyl—Anaphylactic shock—Methotrexate—ankylosing spondylitis	4.88e-05	0.000457	CcSEcCtD
Fentanyl—Dizziness—Methylprednisolone—ankylosing spondylitis	4.87e-05	0.000456	CcSEcCtD
Fentanyl—Infection—Methotrexate—ankylosing spondylitis	4.85e-05	0.000454	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisone—ankylosing spondylitis	4.81e-05	0.00045	CcSEcCtD
Fentanyl—Asthenia—Dexamethasone—ankylosing spondylitis	4.81e-05	0.00045	CcSEcCtD
Fentanyl—Asthenia—Betamethasone—ankylosing spondylitis	4.81e-05	0.00045	CcSEcCtD
Fentanyl—Nervous system disorder—Methotrexate—ankylosing spondylitis	4.78e-05	0.000448	CcSEcCtD
Fentanyl—Thrombocytopenia—Methotrexate—ankylosing spondylitis	4.78e-05	0.000447	CcSEcCtD
Fentanyl—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.77e-05	0.000447	CcSEcCtD
Fentanyl—Nausea—Prednisolone—ankylosing spondylitis	4.77e-05	0.000447	CcSEcCtD
Fentanyl—Pruritus—Betamethasone—ankylosing spondylitis	4.74e-05	0.000444	CcSEcCtD
Fentanyl—Pruritus—Dexamethasone—ankylosing spondylitis	4.74e-05	0.000444	CcSEcCtD
Fentanyl—Skin disorder—Methotrexate—ankylosing spondylitis	4.74e-05	0.000444	CcSEcCtD
Fentanyl—Hyperhidrosis—Methotrexate—ankylosing spondylitis	4.72e-05	0.000442	CcSEcCtD
Fentanyl—Vomiting—Triamcinolone—ankylosing spondylitis	4.7e-05	0.00044	CcSEcCtD
Fentanyl—Vomiting—Methylprednisolone—ankylosing spondylitis	4.69e-05	0.000439	CcSEcCtD
Fentanyl—Rash—Triamcinolone—ankylosing spondylitis	4.66e-05	0.000436	CcSEcCtD
Fentanyl—Dermatitis—Triamcinolone—ankylosing spondylitis	4.65e-05	0.000436	CcSEcCtD
Fentanyl—Anorexia—Methotrexate—ankylosing spondylitis	4.65e-05	0.000435	CcSEcCtD
Fentanyl—Rash—Methylprednisolone—ankylosing spondylitis	4.65e-05	0.000435	CcSEcCtD
Fentanyl—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.64e-05	0.000435	CcSEcCtD
Fentanyl—Urticaria—Prednisone—ankylosing spondylitis	4.64e-05	0.000434	CcSEcCtD
Fentanyl—Headache—Triamcinolone—ankylosing spondylitis	4.63e-05	0.000433	CcSEcCtD
Fentanyl—Headache—Methylprednisolone—ankylosing spondylitis	4.62e-05	0.000432	CcSEcCtD
Fentanyl—Abdominal pain—Prednisone—ankylosing spondylitis	4.61e-05	0.000432	CcSEcCtD
Fentanyl—Body temperature increased—Prednisone—ankylosing spondylitis	4.61e-05	0.000432	CcSEcCtD
Fentanyl—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.59e-05	0.000429	CcSEcCtD
Fentanyl—Diarrhoea—Betamethasone—ankylosing spondylitis	4.59e-05	0.000429	CcSEcCtD
Fentanyl—Hypotension—Methotrexate—ankylosing spondylitis	4.56e-05	0.000427	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.44e-05	0.000416	CcSEcCtD
Fentanyl—Dizziness—Betamethasone—ankylosing spondylitis	4.43e-05	0.000415	CcSEcCtD
Fentanyl—Dizziness—Dexamethasone—ankylosing spondylitis	4.43e-05	0.000415	CcSEcCtD
Fentanyl—Insomnia—Methotrexate—ankylosing spondylitis	4.41e-05	0.000413	CcSEcCtD
Fentanyl—Nausea—Triamcinolone—ankylosing spondylitis	4.39e-05	0.000411	CcSEcCtD
Fentanyl—Paraesthesia—Methotrexate—ankylosing spondylitis	4.38e-05	0.00041	CcSEcCtD
Fentanyl—Nausea—Methylprednisolone—ankylosing spondylitis	4.38e-05	0.00041	CcSEcCtD
Fentanyl—Dyspnoea—Methotrexate—ankylosing spondylitis	4.35e-05	0.000407	CcSEcCtD
Fentanyl—Somnolence—Methotrexate—ankylosing spondylitis	4.34e-05	0.000406	CcSEcCtD
Fentanyl—Hypersensitivity—Prednisone—ankylosing spondylitis	4.3e-05	0.000403	CcSEcCtD
Fentanyl—Dyspepsia—Methotrexate—ankylosing spondylitis	4.29e-05	0.000402	CcSEcCtD
Fentanyl—Vomiting—Betamethasone—ankylosing spondylitis	4.26e-05	0.000399	CcSEcCtD
Fentanyl—Vomiting—Dexamethasone—ankylosing spondylitis	4.26e-05	0.000399	CcSEcCtD
Fentanyl—Decreased appetite—Methotrexate—ankylosing spondylitis	4.24e-05	0.000397	CcSEcCtD
Fentanyl—Rash—Dexamethasone—ankylosing spondylitis	4.23e-05	0.000396	CcSEcCtD
Fentanyl—Rash—Betamethasone—ankylosing spondylitis	4.23e-05	0.000396	CcSEcCtD
Fentanyl—Dermatitis—Betamethasone—ankylosing spondylitis	4.22e-05	0.000395	CcSEcCtD
Fentanyl—Dermatitis—Dexamethasone—ankylosing spondylitis	4.22e-05	0.000395	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.21e-05	0.000394	CcSEcCtD
Fentanyl—Fatigue—Methotrexate—ankylosing spondylitis	4.21e-05	0.000394	CcSEcCtD
Fentanyl—Headache—Dexamethasone—ankylosing spondylitis	4.2e-05	0.000393	CcSEcCtD
Fentanyl—Headache—Betamethasone—ankylosing spondylitis	4.2e-05	0.000393	CcSEcCtD
Fentanyl—Asthenia—Prednisone—ankylosing spondylitis	4.19e-05	0.000392	CcSEcCtD
Fentanyl—Pain—Methotrexate—ankylosing spondylitis	4.17e-05	0.000391	CcSEcCtD
Fentanyl—Pruritus—Prednisone—ankylosing spondylitis	4.13e-05	0.000387	CcSEcCtD
Fentanyl—Feeling abnormal—Methotrexate—ankylosing spondylitis	4.02e-05	0.000376	CcSEcCtD
Fentanyl—Diarrhoea—Prednisone—ankylosing spondylitis	3.99e-05	0.000374	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	3.99e-05	0.000374	CcSEcCtD
Fentanyl—Nausea—Dexamethasone—ankylosing spondylitis	3.98e-05	0.000373	CcSEcCtD
Fentanyl—Nausea—Betamethasone—ankylosing spondylitis	3.98e-05	0.000373	CcSEcCtD
Fentanyl—Urticaria—Methotrexate—ankylosing spondylitis	3.88e-05	0.000363	CcSEcCtD
Fentanyl—Dizziness—Prednisone—ankylosing spondylitis	3.86e-05	0.000361	CcSEcCtD
Fentanyl—Body temperature increased—Methotrexate—ankylosing spondylitis	3.86e-05	0.000361	CcSEcCtD
Fentanyl—Abdominal pain—Methotrexate—ankylosing spondylitis	3.86e-05	0.000361	CcSEcCtD
Fentanyl—Vomiting—Prednisone—ankylosing spondylitis	3.71e-05	0.000348	CcSEcCtD
Fentanyl—Rash—Prednisone—ankylosing spondylitis	3.68e-05	0.000345	CcSEcCtD
Fentanyl—Dermatitis—Prednisone—ankylosing spondylitis	3.68e-05	0.000344	CcSEcCtD
Fentanyl—Headache—Prednisone—ankylosing spondylitis	3.66e-05	0.000342	CcSEcCtD
Fentanyl—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.59e-05	0.000337	CcSEcCtD
Fentanyl—Asthenia—Methotrexate—ankylosing spondylitis	3.5e-05	0.000328	CcSEcCtD
Fentanyl—Nausea—Prednisone—ankylosing spondylitis	3.47e-05	0.000325	CcSEcCtD
Fentanyl—Pruritus—Methotrexate—ankylosing spondylitis	3.45e-05	0.000323	CcSEcCtD
Fentanyl—Diarrhoea—Methotrexate—ankylosing spondylitis	3.34e-05	0.000313	CcSEcCtD
Fentanyl—Dizziness—Methotrexate—ankylosing spondylitis	3.23e-05	0.000302	CcSEcCtD
Fentanyl—Vomiting—Methotrexate—ankylosing spondylitis	3.1e-05	0.00029	CcSEcCtD
Fentanyl—Rash—Methotrexate—ankylosing spondylitis	3.08e-05	0.000288	CcSEcCtD
Fentanyl—Dermatitis—Methotrexate—ankylosing spondylitis	3.07e-05	0.000288	CcSEcCtD
Fentanyl—Headache—Methotrexate—ankylosing spondylitis	3.06e-05	0.000286	CcSEcCtD
Fentanyl—Nausea—Methotrexate—ankylosing spondylitis	2.9e-05	0.000271	CcSEcCtD
